{"calculatePct":false,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"61"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"CR/CRi positive"},{"categories":[{"measurements":[{"groupId":"OG000","value":"6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"NR positive"},{"categories":[{"measurements":[{"groupId":"OG000","value":"11"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Unknown positive"},{"categories":[{"measurements":[{"groupId":"OG000","value":"78"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"79"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"All Patients positive"}],"denoms":[{"counts":[{"groupId":"OG000","value":"79"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"description":"This is defined as the percentage of participants who tested positive for anti-mCAR19 antibodies at any time post-baseline, reported by CR/CRi, no response (NR), Unknown and by All participants. .","groups":[{"description":"Pediatric patients with relapsed or refractory B-cell ALL who were treated with single dose of tisagenlecleucel (CTL019).","id":"OG000","title":"Main Cohort: Single Dose of CTL019"},{"description":"Pediatric B-ALL patients who are very high risk at first relapse.","id":"OG001","title":"Cohort 1: Single Dose of CTL019"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Safety Set: The Safety set comprised all patients who received tisagenlecleucel infusion in the Main Cohort. No participants in Cohort 1 had immunogenicity data providing evaluable cellular kinetic data for tisagenlecleucel at this time point, so no data was collected for Cohort 1.","reportingStatus":"POSTED","timeFrame":"At any time post-baseline, up to a max. of 60 months","title":"Prevalence and Incidence of Immunogenicity to Tisagenlecleucel (CTL019)","type":"SECONDARY","unitOfMeasure":"Participants"}